BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Podrazil M, Taborska P, Stakheev D, Rataj M, Lastovicka J, Vlachova A, Pohunek P, Bartunkova J, Smrz D. Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy. Front Immunol 2022;13:892277. [DOI: 10.3389/fimmu.2022.892277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Calzetta L, Chetta A, Aiello M, Frizzelli A, Ora J, Melis E, Facciolo F, Ippoliti L, Magrini A, Rogliani P. The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma. Vaccines 2023;11:282. [DOI: 10.3390/vaccines11020282] [Reference Citation Analysis]
2 Carr TF, Fajt ML, Kraft M, Phipatanakul W, Szefler SJ, Zeki AA, Peden DB, White SR; Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network Research Group. Treating asthma in the time of COVID. J Allergy Clin Immunol 2022:S0091-6749(22)02454-X. [PMID: 36528110 DOI: 10.1016/j.jaci.2022.12.800] [Reference Citation Analysis]
3 Kim SR. Viral Infection and Airway Epithelial Immunity in Asthma. IJMS 2022;23:9914. [DOI: 10.3390/ijms23179914] [Cited by in F6Publishing: 1] [Reference Citation Analysis]